Yu Chen Jiao
Chief Tech/Sci/R&D Officer bij GENETRON HOLDINGS LIMITED
Vermogen: 17 M $ op 31-03-2024
Actieve functies van Yu Chen Jiao
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENETRON HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 01-08-2017 | - |
Beijing Genetron Health Gene Technology Co., Ltd.
 Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Director/Board Member | - | - |
| Chinese Academy of Medical Sciences | Corporate Officer/Principal | 01-12-2013 | - |
Loopbaan van Yu Chen Jiao
Opleiding van Yu Chen Jiao
| The Johns Hopkins University | Doctorate Degree |
| Peking Union Medical College | Doctorate Degree |
Statistieken
Internationaal
| China | 4 |
| Verenigde Staten | 2 |
| Kaaimaneilanden | 2 |
Operationeel
| Doctorate Degree | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 4 |
| Technology Services | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Beijing Genetron Health Gene Technology Co., Ltd.
Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Technology Services |
Genetron Holdings Ltd.
 Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
- Beurs
- Insiders
- Yu Chen Jiao
- Ervaring
